DermTech (DMTK)
(Delayed Data from NSDQ)
$0.60 USD
+0.02 (3.02%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.60 0.00 (-0.51%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for DermTech, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 56 | 126 | 225 | 64 | 15 |
Receivables | 3 | 4 | 4 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1 | 2 | 0 | 0 | 0 |
Other Current Assets | 2 | 4 | 3 | 2 | 1 |
Total Current Assets | 62 | 136 | 233 | 67 | 17 |
Net Property & Equipment | 5 | 6 | 5 | 3 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 4 | 3 | 0 | 0 |
Total Assets | 122 | 202 | 248 | 70 | 18 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 11 | 6 | 3 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1 | 1 | 3 |
Total Current Liabilities | 13 | 16 | 12 | 5 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 65 | 70 | 19 | 6 | 6 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 481 | 456 | 436 | 190 | 104 |
Retained Earnings | -424 | -323 | -206 | -126 | -91 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 57 | 132 | 230 | 63 | 12 |
Total Liabilities & Shareholder's Equity | 122 | 202 | 248 | 70 | 18 |
Total Common Equity | 57 | 132 | 230 | 63 | 12 |
Shares Outstanding | 34.20 | 30.20 | 29.70 | 20.70 | 12.30 |
Book Value Per Share | 1.67 | 4.38 | 7.73 | 3.07 | 1.02 |
Fiscal Year End for DermTech, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 56 | 68 | 86 | 105 |
Receivables | NA | 3 | 4 | 4 | 4 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 1 | 1 | 2 |
Other Current Assets | NA | 2 | 3 | 2 | 2 |
Total Current Assets | NA | 62 | 76 | 94 | 112 |
Net Property & Equipment | NA | 5 | 6 | 6 | 6 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 3 | 3 | 3 | 4 |
Total Assets | NA | 122 | 138 | 157 | 177 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 2 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 9 | 8 | 11 | 12 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 13 | 13 | 16 | 16 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 65 | 65 | 69 | 70 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 481 | 478 | 474 | 462 |
Retained Earnings | NA | -424 | -405 | -386 | -354 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 57 | 73 | 88 | 107 |
Total Liabilities & Shareholder's Equity | NA | 122 | 138 | 157 | 177 |
Total Common Equity | 0 | 57 | 73 | 88 | 107 |
Shares Outstanding | 34.60 | 34.20 | 34.20 | 33.60 | 31.00 |
Book Value Per Share | 0.00 | 1.67 | 2.14 | 2.62 | 3.46 |